ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLSD Clearside Biomedical Inc

1.69
-0.02 (-1.17%)
Mar 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 858,134
Bid Price 1.57
Ask Price 1.71
News (1)
Day High 1.78

Low
0.650101

52 Week Range

High
2.12

Day Low 1.4901
Company Name Stock Ticker Symbol Market Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.17% 1.69 19:54:25
Open Price Low Price High Price Close Price Prev Close
1.78 1.4901 1.78 1.56 1.71
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,975 858,134 $ 1.63 $ 1,402,972 - 0.650101 - 2.12
Last Trade Time Type Quantity Stock Price Currency
19:31:07 84 $ 1.68 USD

Clearside Biomedical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
99.23M 62.41M - 1.33M -32.95M -0.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Clearside Biomedical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CLSD Message Board. Create One! See More Posts on CLSD Message Board See More Message Board Posts

Historical CLSD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.802.121.49011.77928,176-0.11-6.11%
1 Month1.252.121.201.65620,0660.4435.20%
3 Months1.052.121.021.52335,6620.6460.95%
6 Months0.862.120.6501011.33229,6640.8396.51%
1 Year1.032.120.6501011.25184,6930.6664.08%
3 Years2.847.730.6501013.45557,586-1.15-40.49%
5 Years1.507.730.562.82590,9560.1912.67%

Clearside Biomedical Description

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

Your Recent History

Delayed Upgrade Clock